Arimidex 1 - Dragon Pharma

Anastrozole also known as "Arimidex" was first brought to the market by "Zeneca Pharmaceuticals" It received FDA approval in 1995 as part of the third generation of aromatase inhibitors aimed at inhibiting estrogen production by blocking the aromatase enzyme activity in the body. This drugs primary function is beneficial, for postmenopausal women diagnosed with hormone breast cancer as it offers a treatment alternative that aids in decreasing tumor growth driven by estrogen.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Arimidex 1 by Dragon Pharma, consult with your doctor or healthcare professional.